Coccidioidomycosis – Diagnostic Test Involves Taking Swab Test

Known by other names such as Coccidioidomycosis, dermatomycosis, dermatobacterial infection and staphylococcus aureus (these names where actually derived from the Greek word “occido” meaning infection and “oes” meaning disease), this species of bacteria is the cause of a wide range of skin conditions. This includes acne, which commonly manifest as whiteheads and blackheads in adults; as well as common cold and the flu. The underlying cause of the outbreaks is believed to be the intrusion by some unseen yeast into the immune system’s pilosebaceous unit (POB), which is responsible for controlling the spread of acne from one port to the next. When this happens, the POB reacts to the invasion with inflammation, resulting in a release of P. acnes (the bacteria behind the symptoms) which then causes lesions. As yet, no specific test to confirm the diagnosis has been devised.

Testing for the fungus through microscopic examination of skin scrapings (cyanogamicum or cilia counting) reveals low levels of the organism. One of the most effective ways of diagnosing this condition is by performing a nucleic acid amplification (NAg) test, whereby genetic RNA strands (nucleic acid) are extracted from the patient’s blood samples and run through a procedure that amplifies the sequences. In a nutshell, nucleic acid amplification (NAg) tests are performed on behalf of healthcare providers to confirm whether a patient possesses a strain of the fungus that causes this condition. Accordingly, a nucleic acid probe is used to identify if the specific nucleic acid contained in the probe matches that of the patient’s condition. If this match is confirmed, the condition is considered to be confirmed, or covid-19 infection is diagnosed.

Nucleic acid amplification (NAg) tests are usually performed on patients suspected of having coccidioidomycosis with the use of a prophylactic agent, and this involves taking a sample of the patient’s blood (or other fluid) and then running it through an amplifier that creates copies of every amplified strand of DNA in the sample. The test results are read and compared against a list of strains known to cause coccidioidomycosis. Further confirmation is achieved through further analysis using molecular biology and enzyme reactions. Finally, the results are read and interpreted and the patient is diagnosed with this opportunistic virus.